Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Kidney Transplant Program

Patient Referrals for Kidney Transplant

The transplant process begins with the patient’s referral to the kidney transplant program.

There are three ways for patients to get referred to our program:

  • Patients may refer themselves.
  • Nephrologists can refer patients.
  • Dialysis centers can refer patients.

We also have a secure online web form also provides convenience in requesting an appointment. Or click Request an Appointment on the right side of this page.

Patients will then complete an initial interview over the phone with one of the members of our expert team before moving to the next step.
With the patient’s permission to collect medical records, our team will then begin the process of reviewing pertinent information to plan for a possible testing and a full Evaluation day.

A letter will be sent to the patient and referring physician indicating the routine health maintenance testing necessary prior to beginning the evaluation process. The most efficient way to progress through the evaluation is to have this testing completed prior to the initial evaluation appointments.

  • Dental Clearance – if required by insurance.
  • PAP test – all females age 18 and older.
  • Mammogram – all females age 40 and older.
  • Colonoscopy – all patients age 50 and older.

Patients that are actively smoking will be offered a screening visit with one of the ChristianaCare smoking cessation coaches. This service can be reached 302-661-3300.

Patients may also consider contacting the Delaware Quitline at 866-409-1858.

Patients with a Body Mass Index (BMI) above 38 will be offered a range of service as directed by our transplant dietitian. Patients will be considered for a full evaluation once their weight loss goals have been met.